NEU neuren pharmaceuticals limited

Ann: 2023 Results webinar, page-69

  1. 1,639 Posts.
    lightbulb Created with Sketch. 371
    I wonder if a breakthrough therapy application will go to the FDA in relation to PM. As Jon said the results well exceeded their expectations.

    BT is designed to expediate development of drugs "intended to treat a serious condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on a clinically significant endpoint(s)"

    https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/breakthrough-therapy
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.000(0.00%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.61 $12.68 $12.32 $7.219M 577.9K

Buyers (Bids)

No. Vol. Price($)
1 2968 $12.51
 

Sellers (Offers)

Price($) Vol. No.
$12.57 540 1
View Market Depth
Last trade - 16.16pm 25/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.